Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-067267
Filing Date
2005-03-31
Accepted
2005-03-31 17:16:01
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 955622
2 AMENDED AND RESTATED BY-LAWS OF THE COMPANY dex32.htm EX-3.2 64376
3 EMPLOYMENT AGREEMENT dex1028.htm EX-10.28 65416
4 SALE AGREEMENT DATED OCTOBER 12, 2004 dex1029.htm EX-10.29 417360
5 LEASE FOR PROPERTY DATED MARCH 1, 2005 dex1031.htm EX-10.31 376777
6 ADDENDUM TO THE EMPLOYMENT LETTER dex1032.htm EX-10.32 39100
7 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1758
8 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 8798
9 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 8648
10 SECTION 906 CERTIFICATION OF CEO & CFO dex321.htm EX-32.1 4592
  Complete submission text file 0001193125-05-067267.txt   1945266
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
SIRNA THERAPEUTICS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27914 | Film No.: 05721747
SIC: 2834 Pharmaceutical Preparations